PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers

MLA

Bryan K. Kee, et al. “PIK3CA Mutations in Plasma Circulating Tumor DNA Predict Survival and Treatment Outcomes in Patients with Advanced Cancers.” ESMO Open, vol. 6, no. 5, Mar. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ec5bcfe946ed471c598f2b1cc722a2f1&authtype=sso&custid=ns315887.

APA

Bryan K. Kee, Ecaterina Elena Dumbrava, Siquing Fu, David R. Fogelman, Kimberly Koenig, Abha Adat, S.G. Call, E. S. Kopetz, Filip Janku, Haojie Huang, David S. Hong, Sarina Anne Piha-Paul, A.L. Stuckett, Kiran Madwani, Carlos H. Barcenas, Vivek Subbiah, Apostolia-Maria Tsimberidou, S. L. Moulder, Funda Meric-Bernstam, … Daniel D. Karp. (2021). PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers. ESMO Open, 6(5).

Chicago

Bryan K. Kee, Ecaterina Elena Dumbrava, Siquing Fu, David R. Fogelman, Kimberly Koenig, Abha Adat, S.G. Call, et al. 2021. “PIK3CA Mutations in Plasma Circulating Tumor DNA Predict Survival and Treatment Outcomes in Patients with Advanced Cancers.” ESMO Open 6 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ec5bcfe946ed471c598f2b1cc722a2f1&authtype=sso&custid=ns315887.